Farmacias Benavides S.A.B. de C.V. (BEVIDESB) - Total Liabilities
Based on the latest financial reports, Farmacias Benavides S.A.B. de C.V. (BEVIDESB) has total liabilities worth MX$5.49 Billion MXN (≈ $315.88 Million USD) as of September 2018. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Farmacias Benavides S.A.B. de C.V. (BEVIDESB) net asset momentum to track the company's year-over-year net asset growth rate.
Farmacias Benavides S.A.B. de C.V. - Total Liabilities Trend (2000–2023)
This chart illustrates how Farmacias Benavides S.A.B. de C.V.'s total liabilities have evolved over time, based on quarterly financial data. See Farmacias Benavides S.A.B. de C.V. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Farmacias Benavides S.A.B. de C.V. Competitors by Total Liabilities
The table below lists competitors of Farmacias Benavides S.A.B. de C.V. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Concord Securities Co Ltd
TWO:6016
|
Taiwan | NT$41.93 Billion |
|
Shanghai Labway Clinical Laboratory Co Ltd
SHE:301060
|
China | CN¥666.33 Million |
|
MIDEA REAL HLDG HD 1
F:MR9
|
Germany | €4.59 Billion |
|
Tat Techno
NASDAQ:TATT
|
USA | $52.33 Million |
|
Zevra Therapeutics Inc.
NASDAQ:ZVRA
|
USA | $136.95 Million |
|
GS P&L CO LTD
KO:499790
|
Korea | ₩1.17 Trillion |
|
Shandong Wohua Pharmaceutical Co Ltd
SHE:002107
|
China | CN¥256.47 Million |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
|
China | CN¥420.46 Million |
Liability Composition Analysis (2000–2023)
This chart breaks down Farmacias Benavides S.A.B. de C.V.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Farmacias Benavides S.A.B. de C.V..
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 8.90 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.90 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Farmacias Benavides S.A.B. de C.V.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Farmacias Benavides S.A.B. de C.V. (2000–2023)
The table below shows the annual total liabilities of Farmacias Benavides S.A.B. de C.V. from 2000 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | MX$8.56 Billion ≈ $492.46 Million |
+13.43% |
| 2022-12-31 | MX$7.54 Billion ≈ $434.14 Million |
+8.97% |
| 2021-12-31 | MX$6.92 Billion ≈ $398.41 Million |
-12.18% |
| 2020-12-31 | MX$7.88 Billion ≈ $453.66 Million |
-6.06% |
| 2019-12-31 | MX$8.39 Billion ≈ $482.93 Million |
+40.78% |
| 2018-12-31 | MX$5.96 Billion ≈ $343.05 Million |
+18.57% |
| 2017-12-31 | MX$5.03 Billion ≈ $289.33 Million |
+17.19% |
| 2016-12-31 | MX$4.29 Billion ≈ $246.88 Million |
+13.26% |
| 2015-12-31 | MX$3.79 Billion ≈ $217.99 Million |
-6.95% |
| 2014-12-31 | MX$4.07 Billion ≈ $234.26 Million |
+15.88% |
| 2013-12-31 | MX$3.51 Billion ≈ $202.16 Million |
+22.78% |
| 2012-12-31 | MX$2.86 Billion ≈ $164.65 Million |
+8.01% |
| 2011-12-31 | MX$2.65 Billion ≈ $152.43 Million |
+0.93% |
| 2010-12-31 | MX$2.62 Billion ≈ $151.02 Million |
+3.35% |
| 2009-12-31 | MX$2.54 Billion ≈ $146.13 Million |
-13.97% |
| 2008-12-31 | MX$2.95 Billion ≈ $169.86 Million |
+18.26% |
| 2007-12-31 | MX$2.50 Billion ≈ $143.63 Million |
+29.31% |
| 2006-12-31 | MX$1.93 Billion ≈ $111.08 Million |
+21.28% |
| 2005-12-31 | MX$1.59 Billion ≈ $91.59 Million |
+15.00% |
| 2004-12-31 | MX$1.38 Billion ≈ $79.64 Million |
+4.53% |
| 2003-12-31 | MX$1.32 Billion ≈ $76.19 Million |
+3.25% |
| 2002-12-31 | MX$1.28 Billion ≈ $73.79 Million |
-23.74% |
| 2001-12-31 | MX$1.68 Billion ≈ $96.76 Million |
-1.16% |
| 2000-12-31 | MX$1.70 Billion ≈ $97.90 Million |
-- |
About Farmacias Benavides S.A.B. de C.V.
Farmacias Benavides, S.A.B. de C.V. engages in the retail of health and wellness products. The company also provides medicamentos, non-perishable food, and hygiene and beauty products, as well as photography. The company was founded in 1917 and is based in Monterrey, Mexico. Farmacias Benavides, S.A.B. de C.V. operates as a subsidiary of Walgreens Boots Alliance, Inc.